Spironolactone Tablet, Coated
Product Images NDC 68071-3969

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3969 1)

Pdp (68071 3969 1)
Packaging label for Spironolactone 25 mg coated tablets by NuCare Pharmaceuticals, Inc. The label displays the NDC 68071-3969-1 and the package contains 100 tablets. It includes dosing instructions and warnings, manufacturer and distributor information, storage conditions, and regulatory details such as serial numbers and lot numbers on the right side.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve illustrating probability over time in months for two groups: Spironolactone and Placebo. The y-axis shows probability from 0 to 1, with Spironolactone having a higher survival probability than Placebo. The graph includes sample sizes (Spironolactone n=822, Placebo n=841) and a significant log-rank p-value less than 0.001.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone versus placebo. The plot includes subgroups based on age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The HR scale ranges from 0.2 to 1.4, indicating whether spironolactone or placebo is favored.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone, showing its steroid nucleus and attached functional groups including a lactone ring and thioacetate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.